Phibro Animal Health (PAHC) Tops Q2 EPS by 4c, Reaffirms FY17 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Phibro Animal Health Corp. (PAHC) PT Raised to $34 at Piper Jaffray
February 8, 2017 9:17 AM ESTPiper Jaffray raised its price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $34.00 (from $32.00) while maintaining a Overweight rating. Phibro reported in-line revenues and upside to earnings for 2Q17, where revenues of $192M were only slightly below the Street's estimates of $193M, while... More
